Related content

Prevalence of BRCA2 and CDKN2a mutations in German familial pancreatic cancer families

By Slater Emily   Langer Peter   Fendrich Volker   Habbe Nils   Chaloupka Brunhilde   Matthäi Elvira   Sina Mercedes   Hahn Stephan   Bartsch Detlef  

Familial Cancer, Vol. 9, Iss. 3, 2010-09 ,pp. : 335-343

Springer Publishing Company

Access to resources Recommend Favorite

Promoter methylation of DAPK1, FHIT, MGMT, and CDKN2A genes in cervical carcinoma

By Banzai Chiaki   Nishino Koji   Quan Jinhua   Yoshihara Kosuke   Sekine Masayuki   Yahata Tetsuro   Tanaka Kenichi  

International Journal of Clinical Oncology, Vol. 19, Iss. 1, 2014-02 ,pp. : 127-132

Springer Publishing Company

Access to resources Recommend Favorite

Low-level copy number changes of MYC genes have a prognostic impact in medulloblastoma

By Zitterbart Karel   Filkova Hana   Tomasikova Lenka   Necesalova Eva   Zambo Iva   Kantorova Dagmar   Slamova Iva   Vranova Vladimira   Zezulkova Dita   Pesakova Martina   Pavelka Zdenek   Veselska Renata   Kuglik Petr   Sterba Jaroslav  

Journal of Neuro-Oncology, Vol. 102, Iss. 1, 2011-03 ,pp. : 25-33

Springer Publishing Company

Access to resources Recommend Favorite

The combination of p53 mutation and neu/erbB-2 amplification is associated with poor survival in node-negative breast cancer

By  

The Women's Oncology Review, Vol. 4, Iss. 2, 2004-06 ,pp. : 139-140

Informa Healthcare

Access to resources Recommend Favorite

Screening for exonic copy number mutations at MSH2 and MLH1 by MAPH

By Akrami Seyed   Dunlop Malcolm   Farrington Susan   Frayling Ian   MacDonald Fiona   Harvey John   Armour John  

Familial Cancer, Vol. 4, Iss. 2, 2005-06 ,pp. : 145-149

Springer Publishing Company

Access to resources Recommend Favorite